0000899243-20-006859.txt : 20200303 0000899243-20-006859.hdr.sgml : 20200303 20200303210708 ACCESSION NUMBER: 0000899243-20-006859 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200228 FILED AS OF DATE: 20200303 DATE AS OF CHANGE: 20200303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lawton Alison Frances CENTRAL INDEX KEY: 0001542650 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38822 FILM NUMBER: 20685426 MAIL ADDRESS: STREET 1: 39 ROBINSON ROAD CITY: LEXINGTON STATE: MA ZIP: 02420 FORMER NAME: FORMER CONFORMED NAME: LAWTON ALISON FRANCIS DATE OF NAME CHANGE: 20120216 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kaleido Biosciences, Inc. CENTRAL INDEX KEY: 0001751299 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18 CROSBY DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: 617-674-9000 MAIL ADDRESS: STREET 1: 18 CROSBY DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-28 0 0001751299 Kaleido Biosciences, Inc. KLDO 0001542650 Lawton Alison Frances C/O KALEIDO BIOSCIENCES, INC. 65 HAYDEN AVE. LEXINGTON MA 02421 1 1 0 0 See Remarks Restricted Stock Units 2020-02-28 4 A 0 46325 0.00 A Common Stock 46325 46325 D Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The restricted stock units shall vest 100% on February 28, 2022. President and Chief Executive Officer /s/Alison Lawton 2020-03-03